Danish Commercial Services Stock News

Zealand Pharma (CPSE:ZEAL) opened Q1 2026 with revenue of DKK 34 million, a basic EPS loss of DKK 5.58 and net income loss of DKK 394 million, setting a very different tone against the backdrop of a trailing twelve month EPS of DKK 90.74 and net income of DKK 6.4b. Over recent quarters the company has seen revenue move from DKK 8.09 million in Q1 2025 to DKK 9.06 million in Q4 2024 and then up to DKK 9.09b in Q2 2025, while quarterly EPS has swung from a loss of DKK 4.11 in Q4 2024 to a...

Trifork Group AG ( CPH:TRIFOR ) just released its latest first-quarter report and things are not looking great. It...

As you might know, DFDS A/S ( CPH:DFDS ) recently reported its first-quarter numbers. Revenues were kr.7.4b, with DFDS...

A.P. Møller - Mærsk (CPSE:MAERSK B) opened 2026 with Q1 revenue of about US$13.0b, Basic EPS of US$4, and net income of US$53m, setting a measured tone for the new financial year. The company’s quarterly revenue moved from about US$14.6b in Q4 2024 to roughly US$13.3b in Q1 2025 and then to about US$13.0b in Q1 2026. Over the same period, Basic EPS shifted from US$131.42 in Q4 2024 to US$74.00 in Q1 2025 and then to US$4 in Q1 2026. These shifts feed directly into how you might think about...

Ørsted (CPSE:ORSTED) opened 2026 with Q1 revenue of DKK 27.6b and basic EPS of DKK 1.6, setting a clear marker after a volatile run of quarterly results. The company has seen quarterly revenue move from DKK 20.7b in Q1 2025 to DKK 27.6b in Q1 2026, while EPS shifted from DKK 10.57 a year ago through several loss making quarters to DKK 1.6 this quarter. This gives investors a fresh read on how margins are shaping up after a period of trailing 12 month losses and forecasted earnings growth...

AL Sydbank (CPSE:ALSYDB) opened 2026 with Q1 revenue of DKK 2.9b and basic EPS of DKK 9, alongside trailing 12 month revenue of DKK 9.5b and EPS of DKK 32.39 that reflect a mixed year including a large one off loss. The company has seen quarterly revenue range from DKK 1.6b in Q4 2024 to DKK 3.2b in Q4 2025, while basic EPS has swung between DKK 6.88 and a small loss of DKK 0.64 over that span. This context sets the stage for investors to focus on how current profit margins compare with last...

GN Store Nord (CPSE:GN) opened Q1 2026 with revenue of DKK2.1b and basic EPS of DKK3.06, with earnings from discontinued operations contributing a loss of DKK509m and net income excluding extra items at a loss of DKK446m. Over recent periods, the company has seen quarterly revenue move from DKK5.0b in Q4 2024 to DKK4.7b in Q4 2025 and DKK2.1b in Q1 2026, with basic EPS shifting from DKK2.52 in Q4 2024 to DKK2.36 in Q4 2025 and then to a loss of DKK3.06 in the latest quarter. This puts the...

If you are wondering whether Aktieselskabet Schouw is fairly priced or offering value at its current level, it helps to break the stock down using a few clear valuation angles. The stock last closed at kr665.0, with returns of 2.0% over 7 days, 0.8% over 30 days, 0.2% year to date, 23.2% over 1 year, 27.0% over 3 years and 9.8% over 5 years. This gives you a sense of how the recent share price has behaved across different time frames. Recent news coverage around Aktieselskabet Schouw has...

FLSmidth (CPSE:FLS) has secured significant repeat contracts for a major Banded Hematite Quartzite beneficiation project. The orders cover industry leading technologies, including what is described as the world's largest High Pressure Grinding Roll and several large scale stirred media mills. The equipment package is aligned with FLSmidth's MissionZero ambition, aiming to support more sustainable mining operations. The latest awards add substantial contracted work for the coming years for...

Jyske Bank (CPSE:JYSK) Q1 2026 earnings: softer top line, leaner margins Jyske Bank (CPSE:JYSK) opened 2026 with Q1 revenue of DKK3.1b and net income of DKK984m, translating into basic EPS of DKK16.94. This provides a clear snapshot of how the bank is starting the year. Over the past year, the bank has seen revenue move from DKK14.4b to DKK14.2b on a trailing 12 month basis, while trailing EPS shifted from DKK85.49 to DKK83.22. This gives a sense of how the income statement has been trending...

Ambu (CPSE:AMBU B) has just reported Q2 2026 revenue of DKK1.6b and basic EPS of DKK0.46, with trailing twelve month revenue at DKK6.1b and EPS at DKK1.79 setting the backdrop for the latest quarter. Over recent quarters the company has seen revenue move from DKK1.55b in Q2 2025 to DKK1.57b in Q2 2026, while quarterly EPS has ranged between DKK0.43 and DKK0.71 over the same period. This gives investors a clear view of how earnings are tracking against the top line. With a trailing net profit...

How Zealand Pharma Stock Has Been Performing Zealand Pharma (CPSE:ZEAL) has drawn renewed investor attention after a mixed stretch, with the stock showing gains over the past month but negative moves over the past 3 months, year to date, and the past year. Over the past month, the share price return stands at about 5.8%, while the past 3 months show a decline of around 21.1%. Year to date, the stock is down roughly 31.5%, and the past year reflects a total return decline of about...

Vestas Wind Systems (CPSE:VWS) opened 2026 with Q1 revenue of €3.97b and basic EPS of €0.08, setting the tone for how the year is starting after a busy 2025. Over recent quarters, the company has seen quarterly revenue move from €3.47b and EPS of roughly €0.00 in Q1 2025 to €6.27b and €0.44 in Q4 2025, with trailing twelve month EPS at €0.83 on €19.32b of revenue. This gives investors a clear read on how volumes and profitability are feeding through to the income line as net margins sit at...

Novo Nordisk (CPSE:NOVO B) opened 2026 with Q1 revenue of DKK 96.8b and basic EPS of DKK 10.93, while the trailing twelve months show revenue of DKK 327.8b and EPS of DKK 27.44. Over the past year, revenue has moved from DKK 290.4b to DKK 327.8b and EPS from DKK 22.67 to DKK 27.44 on a trailing basis. This sets a clear benchmark for how current profitability aligns with investor expectations. With net margin running at 37.2% versus 34.5% a year earlier, the latest results put the focus...

Pandora (CPSE:PNDORA) opened 2026 with Q1 revenue of DKK 7.1b and basic EPS of DKK 12.6, alongside net income of DKK 942m, setting a clear marker for how the year is starting after a busy 2025. Over recent quarters the company has seen revenue move between DKK 6.3b and DKK 11.9b, while basic EPS has ranged from DKK 6.3 to DKK 37. This gives you a broad view of how the top and bottom line have tracked through different trading periods. With a trailing net profit margin of 15.7%, the latest...

Q1 2026 results set up a mixed but interesting picture Netcompany Group (CPSE:NETC) has kicked off 2026 with Q1 revenue of DKK 2.4b and basic EPS of DKK 3.15, putting fresh numbers on the table for a stock trading around DKK 356.8. Over the past six reported quarters, revenue has moved from DKK 1.7b in Q4 2024 to DKK 2.4b in Q1 2026. Quarterly EPS has ranged from a loss of DKK 1.44 in Q3 2025 to DKK 3.21 in Q4 2025 and DKK 3.15 in the latest quarter, setting up a results season where...

DSV (CPSE:DSV) just opened 2026 with first quarter results that paired higher sales with lower profitability, while management kept full year EBIT guidance intact, including expected Schenker related synergies. See our latest analysis for DSV. The stock is trading at DKK1,504.5, with a 1 day share price return of 3.47% but a 90 day share price return reflecting an 18.37% decline. Meanwhile, the 1 year total shareholder return of 4.36% and 3 year total shareholder return of 16.58% point to...

This article examines whether Alm. Brand is attractively priced or if the current share price already reflects most of its potential, by breaking down what the current valuation signals may indicate about the stock. The share price recently closed at kr.15.26, with returns of 1.7% over the past week, a 3.6% decline over the last month, and a 1.4% gain over the past year, alongside a 42.0% three year and 13.2% five year return profile. These moves sit against a backdrop of ongoing coverage...

Ringkjøbing Landbobank stock snapshot after recent moves Ringkjøbing Landbobank (CPSE:RILBA) has attracted fresh attention after recent price moves, with the stock showing mixed short term performance alongside longer term total returns and measurable annual growth in revenue and net income. See our latest analysis for Ringkjøbing Landbobank. Recent trading has been relatively steady, with a 1 day share price return of 1.09% and a 7 day share price return of 1.15%. The 1 year total...

DFDS Q1 2026 results set the tone for a profit-focused turnaround story DFDS (CPSE:DFDS) has opened 2026 with Q1 revenue of DKK 7.4b and a basic EPS loss of DKK 3.29, alongside a trailing twelve month net loss of DKK 276m and EPS of DKK 5.11 in the red, which keeps the focus squarely on the path back to profitability. Over recent quarters the company has seen revenue move between DKK 7.2b and DKK 8.3b, while EPS has swung from a loss of DKK 6.09 to a profit of DKK 5.13 before reverting to...

Q1 2026 results set the tone for NTG Nordic Transport Group (CPSE:NTG) NTG Nordic Transport Group (CPSE:NTG) opened 2026 with Q1 revenue of DKK 2,983 million and basic EPS of DKK 2.62, framing the latest quarterly read alongside a trailing twelve month EPS of DKK 10.14 on revenue of DKK 11.67 billion. Over the past year, the company has seen revenue move from DKK 9.35 billion in the trailing twelve months to Q4 2024 to DKK 11.67 billion by Q1 2026, while trailing EPS shifted from DKK 13.94 to...

Maersk's U.S.-flagged vessel Fairfax completed a safe transit of the Strait of Hormuz after being stuck in the Persian Gulf for months. The passage, supported by military escort, marks a key operational development for A.P. Møller Mærsk (CPSE:MAERSK B) in a high-risk shipping corridor. This update adds new detail to the company’s recent experience with Middle East route disruptions and security challenges. A.P. Møller Mærsk, listed as CPSE:MAERSK B, is a global container shipping and...

Trifork Group (CPSE:TRIFOR) has just posted its Q1 2026 scorecard, with recent quarterly context showing Q4 2025 revenue of €59.1 million, basic EPS of €0.44 and net income of €8.5 million. The trailing twelve months to Q4 2025 came in at €221.2 million of revenue, basic EPS of €0.53 and net income of €10.3 million. Over the past few reported quarters, revenue has moved between €47.2 million and €59.1 million, with basic EPS ranging from a slight loss of €0.01 to €0.63 and net income...

Novozymes (CPSE:NSIS B) has opened Q1 2026 earnings season with recent quarterly revenue between €981.4 million and €1.08 billion over the past six reported periods, while quarterly EPS ranged from €0.26 to €0.40, and trailing twelve month EPS most recently sat at €1.25 on €4.16 billion of revenue. Over that stretch, revenue has moved from €3.83 billion and EPS of €1.10 on a trailing basis in Q4 2024 to €4.16 billion and EPS of €1.25 by Q4 2025. With trailing net profit margin at 14% compared...